Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Short term Debt: 2009-2016

Historic Short term Debt for Gyre Therapeutics (GYRE) over the last 7 years, with Sep 2016 value amounting to $28,000.

  • Gyre Therapeutics' Short term Debt fell 95.86% to $28,000 in Q3 2016 from the same period last year, while for Sep 2016 it was $28,000, marking a year-over-year decrease of 95.86%. This contributed to the annual value of $1.2 million for FY2015, which is N/A change from last year.
  • According to the latest figures from Q3 2016, Gyre Therapeutics' Short term Debt is $28,000, which was down 78.46% from $130,000 recorded in Q2 2016.
  • Gyre Therapeutics' 5-year Short term Debt high stood at $1.2 million for Q4 2015, and its period low was $28,000 during Q3 2016.
  • In the last 3 years, Gyre Therapeutics' Short term Debt had a median value of $577,000 in 2014 and averaged $517,375.
  • In the last 5 years, Gyre Therapeutics' Short term Debt spiked by 41.42% in 2015 and then crashed by 95.86% in 2016.
  • Gyre Therapeutics' Short term Debt (Quarterly) stood at $851,000 in 2012, then rose by 0.24% to $853,000 in 2013, then plummeted by 45.25% to $478,000 in 2014, then surged by 41.42% to $1.2 million in 2015, then plummeted by 95.86% to $28,000 in 2016.
  • Its Short term Debt stands at $28,000 for Q3 2016, versus $130,000 for Q2 2016 and $196,000 for Q1 2016.